Ray et al., BioDrugs 2006
(Cardiovascular Diseases...) :
In particular, release of soluble CD40 ligand ( sCD40L ) and thromboxane ( TXA ( 2 ) ) was inhibited by PPARgamma ligands in thrombin activated platelets
Missiou et al., Thromb Haemost 2010
(Cardiovascular Diseases...) :
Furthermore, stimulation with CD40L resulted in enhanced activation of C/EBPa and PPARg and promoted adipogenesis of preadipose cells in the presence and absence of standard adipogenic conditions